05/19/2022 | Press release | Distributed by Public on 05/18/2022 22:28
Louvain-La-Neuve, Belgium, 19 May 2022- IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces its business update for the first quarter ending 31 March 2022.
Group Overview
Olivier Legrain, Chief Executive Officer of IBA commented: "IBA's strong performance has continued into the first quarter of 2022, with good momentum across all business lines on an international scale. Against the backdrop of ongoing global economic and geopolitical challenges, our active pipeline, increasing recurring revenue stream and excellent balance sheet ensure that we are in a robust position to weather any uncertainty."
Proton Therapy
Other Accelerators (RadioPharma, Industrial)
Dosimetry
Outlook
IBA has continued to perform well across all business lines in the first quarter of 2022. Our pipeline remains highly active, particularly in the US and Asia, and, coupled with our growing recurring revenue stream, provides significant visibility on future sales. Alongside this, our balance sheet remains very strong, giving us optionality to support long-term growth.
We have seen a modest impact from the ongoing conflict in Ukraine and its effect on the global supply chain and transportation. Although it is difficult to predict the impact of the conflict on IBA's performance for the rest of the year, the associated disruptions and delays are currently manageable and we continue to work to monitor and mitigate our risks.
Financial calendar
Half year Results 31 August 2022
Business Update Q3 2022 17 November 2022
About IBA
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 1,600 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.
IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at: www.iba-worldwide.com